Apollo Hospitals Enterprise Ltd

AI
Apollo Hospitals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Apollo Hospitals Enterprise Ltd

₹ 8,693 -0.48%
21 Aug - close price
apollohospitals.com BSE: 508869 NSE: APOLLOHOSP F&O
About

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.

Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models. [1]

Key Points

Business Segments:
a) Healthcare Services (50% in FY26 vs 55% in FY22):[1][2][3]
The company has a capacity of 10,970 beds in 78 hospitals located in India and overseas, out of which 9,481 beds are located in 49 owned hospitals, 699 beds in Day Surgery & Cradles and 790 beds are in 6 managed hospitals.
b) Digital Health & Pharmacy Distribution (43% in FY26 vs 37% in FY22):[4]
The WOS Apollo HealthCo (AHL) manages
India’s largest organized pharmacy network, operating across 22 states and 5 union territories, with a presence in 1,200 cities and towns. It has 7,289 active stores. Sales from its offline private and generic labels contribute 15.3% of the total revenue (Q4FY26). Additionally, its online platform, Apollo 24x7, has over 47 million registered users and 9 lakh daily active users.[5]
c) Retail Health & Diagnostics (7% in FY26 vs 8% in FY22):[6]
The WOS Apollo Health & Lifestyle operates 2,501 diagnostics centers, 167 dialysis centers, 280 dental centers, and 316 clinics. As of FY26, the segment has a footfall of 33,461 per day and an average gross realization per patient of Rs. 1,608.[7]

Website BSE NSE F&O
  • Market Cap ₹ 1,24,992 Cr.
  • Current Price ₹ 8,693
  • High / Low ₹ 9,327 / 6,680
  • Stock P/E 59.4
  • Book Value ₹ 659
  • Dividend Yield 0.23 %
  • ROCE 17.4 %
  • ROE 21.2 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has delivered good profit growth of 76.2% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 17.7%

Cons

  • Stock is trading at 13.2 times its book value
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
4,418 4,847 4,851 4,944 5,086 5,589 5,527 5,592 5,842 6,304 6,477 6,606 7,044
3,909 4,219 4,237 4,303 4,410 4,774 4,765 4,822 4,990 5,362 5,512 5,594 5,951
Operating Profit 509 628 614 640 675 816 762 770 852 941 965 1,011 1,092
OPM % 12% 13% 13% 13% 13% 15% 14% 14% 15% 15% 15% 15% 16%
34 26 29 37 49 44 69 72 54 61 48 54 62
Interest 106 111 113 119 116 118 110 115 108 110 113 119 120
Depreciation 167 163 167 190 177 184 185 211 215 218 219 224 235
Profit before tax 270 379 363 368 430 557 536 516 583 675 682 722 799
Tax % 36% 34% 30% 30% 27% 29% 29% 20% 24% 27% 24% 24% 24%
173 249 254 258 316 396 379 414 441 494 516 551 610
EPS in Rs 11.59 16.20 17.06 17.65 21.23 26.34 25.89 27.10 30.10 33.19 34.93 36.81 40.39
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
5,129 6,150 7,256 8,243 9,617 11,247 10,560 14,663 16,612 19,059 21,794 25,228 26,430
4,392 5,465 6,522 7,442 8,548 9,656 9,420 12,474 14,548 16,665 18,761 21,449 22,420
Operating Profit 737 684 734 801 1,070 1,591 1,140 2,189 2,065 2,394 3,033 3,779 4,010
OPM % 14% 11% 10% 10% 11% 14% 11% 15% 12% 13% 14% 15% 15%
47 92 60 24 26 222 103 368 75 123 222 207 226
Interest 118 180 257 295 327 533 449 379 381 449 458 450 462
Depreciation 212 264 314 359 396 620 573 601 615 687 758 876 896
Profit before tax 455 332 222 171 373 660 221 1,578 1,144 1,380 2,039 2,661 2,877
Tax % 29% 29% 41% 65% 47% 34% 38% 30% 22% 32% 26% 25%
335 235 131 60 200 432 137 1,108 844 935 1,505 2,003 2,172
EPS in Rs 24.43 16.99 15.88 8.44 16.96 32.70 10.46 73.42 56.97 62.50 100.56 135.04 145.32
Dividend Payout % 24% 35% 38% 59% 35% 18% 29% 16% 26% 26% 13% 15%
Compounded Sales Growth
10 Years: 15%
5 Years: 19%
3 Years: 15%
TTM: 17%
Compounded Profit Growth
10 Years: 23%
5 Years: 76%
3 Years: 32%
TTM: 34%
Stock Price CAGR
10 Years: 20%
5 Years: 12%
3 Years: 21%
1 Year: 10%
Return on Equity
10 Years: 13%
5 Years: 17%
3 Years: 18%
Last Year: 21%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 70 70 70 70 70 70 72 72 72 72 72 72
Reserves 3,102 3,262 3,244 3,182 3,264 3,270 4,531 5,551 6,126 6,864 8,140 9,408
1,992 2,834 3,125 3,427 3,673 3,596 4,160 4,068 4,332 5,333 7,864 8,493
1,296 1,195 1,665 1,917 2,159 4,354 2,629 3,570 3,886 4,474 4,568 4,210
Total Liabilities 6,459 7,360 8,103 8,596 9,166 11,289 11,392 13,261 14,416 16,742 20,644 22,183
3,244 3,997 4,591 4,773 4,982 7,432 6,778 8,296 8,520 9,664 10,988 12,272
CWIP 533 562 347 712 822 236 234 46 610 873 921 1,032
Investments 311 352 406 352 462 434 1,343 816 574 986 2,487 2,179
2,372 2,448 2,759 2,759 2,901 3,187 3,037 4,104 4,712 5,219 6,248 6,700
Total Assets 6,459 7,360 8,103 8,596 9,166 11,289 11,392 13,261 14,416 16,742 20,644 22,183

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
470 597 623 537 905 1,293 1,265 1,696 1,377 1,920 2,136 2,856
-759 -888 -1,152 -405 -711 -289 -880 -747 -857 -1,537 -3,383 -2,145
392 330 477 -108 -215 -910 -340 -792 -633 -311 1,319 -478
Net Cash Flow 103 39 -52 24 -20 94 44 158 -113 72 73 233
Free Cash Flow -396 -393 -46 -84 233 782 984 1,044 252 785 439 925
CFO/OP 77% 108% 103% 83% 103% 100% 108% 87% 85% 100% 86% 92%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 43 36 38 37 39 33 46 44 49 48 51 50
Inventory Days 50 49 47 51 46 49 16 21 17 17 16 15
Days Payable 59 66 51 55 56 60 74 79 82 88 72 63
Cash Conversion Cycle 34 19 34 33 29 22 -12 -14 -16 -23 -6 3
Working Capital Days 24 16 27 8 -3 -8 -4 5 -1 -19 -6 -25
ROCE % 12% 9% 8% 7% 10% 14% 8% 17% 14% 15% 17% 17%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Apollo Pharmacy Operating Stores
Count

Log in to view insights

Please log in to see hidden values.

Login
ARPOB (Average Revenue per Occupied Bed)
INR per day
Bed Occupancy Rate
%
Inpatient (IP) Discharges
Count
Operating Beds (Healthcare Services)
Beds
Apollo 24/7 Registered Users
Million
Diagnostics Centers (AHLL)
Count
Apollo 24/7 Platform GMV
INR Mn

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.34% 29.34% 28.02% 28.02% 28.02% 28.02%
46.15% 46.25% 45.63% 43.92% 45.37% 45.27% 42.74% 43.49% 44.20% 43.54% 42.62% 41.49%
18.59% 18.87% 19.55% 21.13% 19.94% 19.97% 22.29% 21.34% 21.12% 21.50% 22.76% 23.72%
0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23%
5.68% 5.32% 5.26% 5.38% 5.12% 5.21% 5.41% 5.61% 6.43% 6.71% 6.39% 6.53%
No. of Shareholders 1,31,5651,19,5781,30,6641,27,7541,19,2451,27,8021,34,0581,41,0071,60,5561,78,6481,74,6101,74,281

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls